About the firm

Specialist expertise serving defensible, fundable, and useful healthcare decisions.

The firm

A specialist firm for high-stakes health decisions

Santicxis positions itself as a specialist partner in economic evaluation and decision support for governments, institutions, industry, NGOs, and healthcare organizations.

The firm steps in when resources are constrained, innovations are costly, and decisions must be scientifically robust, economically defensible, and institutionally clear.

Its approach combines advanced economic modeling, data analysis, health policy expertise, and a strong understanding of African and emerging health systems.

Firm signature

Economic evaluation and modeling
Health policy and resource allocation
Africa, francophone systems, and emerging markets

Recognized expertise

More than 12 years of combined experience in economic analysis, modeling, and health decision support, backed by multidisciplinary profiles.

Scientific rigor

Methods aligned with international standards to produce reliable, auditable, decision-ready analyses.

Tailored approach

Each engagement is designed around the client’s constraints, country context, payer environment, or institutional reality.

Founder

Christian Kouakou, PhD

Health economist, researcher, and advisor, Christian Kouakou helps decision-makers optimize healthcare investments across francophone and resource-constrained settings.

His work focuses on the economic value of health, QALYs, health technology assessment, and decision-oriented modeling.

His publications in journals such as European Journal of Health Economics, Value in Health, BMJ Open, and IJERPH reinforce the firm’s scientific credibility.

Useful research

Expertise grounded in published work and methods aligned with international standards.

Decision focus

A strong ability to connect analytical rigor with real payer, regulator, and institutional trade-offs.

Francophone and international reach

A nuanced understanding of health system needs in Africa, Canada, and emerging markets.

We work notably with

Pharmaceutical and biotech companies

Economic value demonstration, pricing strategy, market access, and reimbursement support.

Government organizations

Budget impact, efficiency, equity, and public health prioritization analyses.

NGOs and funders

Assessment of program impact and economic sustainability, with stronger funding cases.

Hospitals and research institutes

Support in study design, data management, and modeling to demonstrate intervention value.

Let’s move

Let’s discuss your strategic healthcare priorities.

Need an economic evaluation, a market access strategy, or a high-level training program? Let’s define the intervention that creates the right impact.

Book a strategic call Contact